TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
0QOK Stock 12 Month Forecast
Average Price Target
CHF302.01
▼(-8.39% Downside)
Based on 12 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF302.01 with a high forecast of CHF356.25 and a low forecast of CHF230.16. The average price target represents a -8.39% change from the last price of CHF329.66.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Regeneron (NASDAQ: REGN) and Roche Holding AG (Other OTC: RHHVF)
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Analysts' Opinions Are Mixed on These Healthcare Stocks: Apogee Therapeutics (NASDAQ: APGE), Regeneron (NASDAQ: REGN) and Roche Holding AG (Other OTC: RHHVF)
BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
trades and holding each position for 1 Month would result in 70.00% of your transactions generating a profit, with an average return of +3.48% per trade.
trades and holding each position for 3 Months would result in 87.50% of your transactions generating a profit, with an average return of +8.97% per trade.
Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +25.43% per trade.
trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +37.24% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
0QOK Analyst Recommendation Trends
Rating
Aug 25
Sep 25
Oct 25
Nov 25
Dec 25
Strong Buy
0
0
0
0
0
Buy
13
15
14
15
12
Hold
8
9
9
10
13
Sell
14
16
16
20
17
Strong Sell
0
0
0
0
0
total
35
40
39
45
42
In the current month, 0QOK has received 12Buy Ratings, 13Hold Ratings, and 17Sell Ratings. 0QOK average Analyst price target in the past 3 months is 302.01.
Each month's total comprises the sum of three months' worth of ratings.
0QOK Financial Forecast
0QOK Earnings Forecast
Next quarter’s earnings estimate for 0QOK is CHF8.55 with a range of CHF8.16 to CHF8.99. The previous quarter’s EPS was CHF11.08. 0QOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0QOK is CHF8.55 with a range of CHF8.16 to CHF8.99. The previous quarter’s EPS was CHF11.08. 0QOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.
0QOK Sales Forecast
Next quarter’s sales forecast for 0QOK is CHF15.55B with a range of CHF14.96B to CHF16.13B. The previous quarter’s sales results were CHF30.94B. 0QOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.
Next quarter’s sales forecast for 0QOK is CHF15.55B with a range of CHF14.96B to CHF16.13B. The previous quarter’s sales results were CHF30.94B. 0QOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.
0QOK Stock Forecast FAQ
What is GB:0QOK’s average 12-month price target, according to analysts?
Based on analyst ratings, Roche Holding AG’s 12-month average price target is 302.01.
What is GB:0QOK’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for GB:0QOK, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Roche Holding AG a Buy, Sell or Hold?
Roche Holding AG has a consensus rating of Hold, which is based on 5 buy ratings, 4 hold ratings and 3 sell ratings.
What is Roche Holding AG’s share price target?
The average share price target for Roche Holding AG is 302.01. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months. The highest analyst share price target is CHF356.25 ,and the lowest forecast is CHF230.16. The average share price target represents -8.39% Decrease from the current price of CHF329.66.
What do analysts say about Roche Holding AG?
Roche Holding AG’s analyst rating consensus is a Hold. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of Roche Holding AG?
To buy shares of GB:0QOK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.